#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-myelin-associated glycoprotein associated polyneuropathy Acquired C1 inhibitor deficiency Parkinson's disease Pneumonia Chronic myeloid leukaemia Inflammatory myofibroblastic tumour Metastases to central nervous system IPEX syndrome Vulval cancer recurrent Hereditary angioedema with C1 esterase inhibitor deficiency Bronchopulmonary aspergillosis Hypersensitivity pneumonitis Chronic cutaneous lupus erythematosus Infantile apnoea Turner's syndrome More trials…

    Learn about Rare Diseases

    KBG syndrome Osteosarcoma Lymphatic malformation – Diagnostics Basal cell naevus syndrome – Life with Disease Factor IX deficiency – Treatment Rhabdoid tumour – Treatment Mantle cell lymphoma refractory – Basic Information Lymphangioma – Basic Information Pelizaeus-Merzbacher disease Rhabdomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vixarelimab ASP3082 Isis 696844 Posaconazole ANGIOTENSIN II Resatorvid ARGININE GLUTAMATE Octreotide Acetate Stiripentol Mva-209-Fsp-B1 IM-101 IBANDRONIC ACID Evg321 Viltolarsen Adenosine Opevesostat Tosilate Paraffin White Soft Avutometinib Elritercept Deflazacort More therapies…

    Learn about Your Condition

    Suicidal ideation Coronary artery dissection Deep vein thrombosis Erythema multiforme Ear discomfort Cardiac failure acute Hyperkalaemia Endometrial cancer stage II Factor IX deficiency Medulloblastoma Bone metabolism disorder Marginal zone lymphoma Hepatic cancer Staphylococcal infection Leiomyosarcoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Melpida with drug combination in patients with Hereditary Spastic Paraplegia Type 50 (SPG50)

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Meglumine Gadoterate
    • Sirolimus
    • Buclizine Hydrochloride
    Spain

  • Ropivacaine hydrochloride versus electrolytes for pain relief in women undergoing second‑trimester medical abortion after 13 weeks

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Mannitol
    Sweden

  • Randomized study of ketotifen nasal spray (0.025% and 0.050%) versus sodium cromoglicate nasal spray in patients with rhinitis

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Sodium Cromoglicate
    Greece

  • Fosfomycin versus drug combination for oral step‑down treatment of febrile urinary tract infections caused by E. coli in men

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Escherichia urinary tract infection
    Investigated Drugs:
    • Fosfomycin
    • Tolu Balsam
    • Ciprofloxacin
    France

  • Study of neoadjuvant intratumoral ipilimumab combined with systemic nivolumab in patients with locally advanced resectable oral cavity squamous cell carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lip and/or oral cavity cancer
    • Squamous cell carcinoma of the oral cavity
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    The Netherlands

  • Efficacy and Safety of Transmucosal Midazolam for Proportional Palliative Sedation in Children with Refractory Symptoms

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Dobutamine Hydrochloride
    France
Previous Page
1 … 676 677 678 679 680 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!